AGN-OLD
ALLERGAN INC/UNITED STATES
ALLERGAN INC/UNITED STATES historical holders
total: 5
Third Point ALLERGAN INC/UNITED STATES transactions over time
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2014 Q4
- Held for:
- 1 quarter
- Latest activity:
- 2015 Q1
Daniel Loeb has been an institutional investor in ALLERGAN INC/UNITED STATES (AGN-OLD) since 2014 Q4. According to 2026 Q1 report, Daniel Loeb doesn't hold any shares. The fund/company first acquired AGN-OLD in 2014 Q4, initially purchasing 400,000 shares. Since the initial investment, Third Point has made 1 more transaction in this position.
When did Daniel Loeb exit their AGN-OLD position?
Daniel Loeb no longer holds ALLERGAN INC/UNITED STATES (AGN-OLD). They sold off their entire position in 2015 Q1, closing out an investment that began in 2014 Q4.
When did Daniel Loeb first invest in AGN-OLD?
Daniel Loeb first invested in ALLERGAN INC/UNITED STATES (AGN-OLD) in 2014 Q4 at the reported quarter-end price of $212.59 per share, acquiring 400,000 shares in their initial purchase.
What is Daniel Loeb's average cost basis for AGN-OLD?
Based on historical transaction data, Daniel Loeb's estimated cost basis for ALLERGAN INC/UNITED STATES (AGN-OLD) is approximately $212.59 per share. This represents their average reported price* across all buy transactions.
Estimated cost basis*
- Weighted AVG buy price:
- $212.59
- Weighted AVG sell price:
- $212.59
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.